Development of BT1718, a Bicycle Drug Conjugate (BDC) targeting MT1-MMP for treatment of solid tumours

被引：12
|
作者：
Bennett, G. [1 ]
Harrison, H. [1 ]
Campbell, S. [1 ]
Teufel, D. [1 ]
Langford, G. [1 ]
Watt, A. [1 ]
Bonny, C. [2 ]
机构：
[1] Bicycle Therapeut Ltd, Therapeut, Cambridge, England
[2] Bicycle Therapeut Ltd, Discovery, Cambridge, England
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32642-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
42
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 27 条
  • [1] The mechanism of action of BT1718, a novel small-molecule drug conjugate for the treatment of solid tumors expressing MT1-MMP
    Bennett, Gavin
    Rigby, Mike
    Lutz, Bob
    Park, Peter
    Keen, Nicholas
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [2] Development of BT1718, a novel Bicycle Drug Conjugate for the treatment of lung cancer
    Bennett, Gavin
    Lutz, Robert
    Park, Peter
    Harrison, Helen
    Lee, Kevin
    CANCER RESEARCH, 2017, 77
  • [3] BT1718, a novel bicyclic peptide-maytansinoid conjugate targeting MT1-MMP for the treatment of solid tumors: Design of bicyclic peptide and linker selection
    Harrison, Helen
    Bennett, Gavin
    Blakeley, Diane
    Brown, Amy
    Campbell, Spencer
    Chen, Liuhong
    Lutz, Robert J.
    Pavan, Silvia
    van Rietschoten, Katerine
    Teufel, Daniel
    Park, Peter U.
    Lee, Kevin
    CANCER RESEARCH, 2017, 77
  • [4] Preliminary pharmacokinetic assessment of BT1718: A phase I/IIa trial of BT1718 (a first in class Bicycle Toxin Conjugate) in patients with advanced solid tumours
    Banerji, U.
    Cook, N.
    Evans, T. R. J.
    Moreno, I.
    Patricia, R.
    Kelly, C.
    Sabaratnam, N.
    Passi, R.
    Godfrey, L.
    Sawretse, L.
    Katugampola, S.
    Halbert, G.
    Jeffrey, P.
    Rigby, M.
    Bennett, G.
    Koehler, M.
    Langford, G.
    Pittman, M.
    Symeonides, S. N.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E65 - E65
  • [5] Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours
    Cook, N.
    Banerji, U.
    Evans, J.
    Biondo, A.
    Germetaki, T.
    Randhawa, M.
    Godfrey, L.
    Leslie, S.
    Jeffrey, P.
    Rigby, M.
    Bennett, G.
    Blakemore, S.
    Koehler, M.
    Niewiarowski, A.
    Pittman, M.
    Symeonides, S. N.
    ANNALS OF ONCOLOGY, 2019, 30 : 174 - 174
  • [6] A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.
    Banerji, Udai
    Cook, Natalie
    Evans, T. R. Jeffry
    Candilejo, Irene Moreno
    Roxburgh, Patricia
    Kelly, Claire L. S.
    Sabaratnam, Narmatha
    Passi, Rashmi
    Leslie, Sawretse
    Katugampola, Sidath
    Godfrey, Lisa
    Tremayne, Neil
    Bennett, Gavin
    Koehler, Maria
    Langford, Gillian
    Symeonides, Stefan N.
    Pittman, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Toxin Conjugate) given intravenously in patients with advanced solid tumours
    Banerji, Udai
    Cook, Natalie
    Evans, T. R. Jeffry
    Candilejo, Irene Moreno
    Roxburgh, Patricia
    Kelly, Claire
    Sabaratnam, Narmatha
    Passi, Rashmi
    Leslie, Sawretse
    Katugampola, Sidath
    Godfrey, Lisa
    Tremayne, Neil
    Halbert, Gavin
    Bennett, Gavin
    Koehler, Maria
    Langford, Gillian
    Pittman, Marc
    Symeonides, Stefan
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 42 - 42
  • [8] MT1-MMP Immunohistochemistry (IHC) analysis of tumor microarrays (TMAs) using a novel scoring system guides patient selection for BT1718 expansion cohorts
    Gelb, Tara
    Bacon, Chris
    Sloan, Philip
    Rigby, Mike
    Guerrera, Stephanie
    Kelly, Fiona
    Symeonides, Stefan
    Blakemore, Stephen J.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [9] Design and characterization of a high affinity and selective bicyclic peptide binder to MT1-MMP for development of a treatment for solid tumours
    Harrison, H.
    Chen, L.
    Teufel, D.
    Van Rietschoten, K.
    Campbell, S.
    Brown, A.
    Blakeley, D.
    Bennett, G.
    Langford, G.
    Bonny, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S69 - S70
  • [10] BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
    Rigby, Michael
    Bennett, Gavin
    Chen, Liuhong
    Mudd, Gemma E.
    Harrison, Helen
    Beswick, Paul J.
    Van Rietschoten, Katerine
    Watcham, Sophie M.
    Scott, Heather S.
    Brown, Amy N.
    Park, Peter U.
    Campbell, Carly
    Haines, Eric
    Lahdenranta, Johanna
    Skynner, Michael J.
    Jeffrey, Phil
    Keen, Nicholas
    Lee, Kevin
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (12) : 1747 - 1756
123